North America dominates the Surgical Dermatome market with a 42% share, driven by high adoption of advanced medical devices, robust healthcare infrastructure, and strong government investments in regenerative medicine. The regionโs Surgical Dermatome market growth is further fueled by a rising aging population and a high prevalence of chronic wounds. Europe follows at 28%, supported by stringent regulatory frameworks ensuring device quality, a mature healthcare ecosystem, and growing focus on wound care innovation. Asia Pacific emerges as the fastest-growing region, with a projected CAGR of 9.5%, driven by expanding healthcare access, increasing disposable incomes, and rising adoption of minimally invasive surgical techniques. Latin America captures 15%, bolstered by public-private partnerships and improving medical tourism infrastructure, while the Middle East & Africa holds 7%, with growth spurred by urbanization and targeted investments in healthcare modernization.